Posts

Genentech’s drug Avastin is used to treat cancer, but has also been used off-label for treatment of eye disease including diabetic retinopathy (DR). Sam Grossman discusses some of the studies’ findings of this medicine and whether people with DR may want to inquire with their healthcare providers about it.

Certified diabetes educator Amy Hess-Fischl talks about using GLP-1 agonists off-label in people with type 1 and shares some anecdotal evidence from patients as well as studies using this drug class in this patient population.